The U.S. Supreme Court reversed and remanded the case of Teva Pharmaceuticals USA, Inc. v Sandoz, Inc., holding that the Federal Circuit must apply a “clear error”, rather than a de novo, standard when reviewing a district court’s claim construction findings.  The opinion can be read here Teva v Sandoz